← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$766K

Shares

17,500

Price

$44

Filed

Jun 11

Insider

Name

Mottiwala Aziz

Title

Chief Commercial Officer

CIK

0001788542

Roles

Officer

Transaction Details

Transaction Date

2025-06-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,557

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $43.42 to $44.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001819790-25-000081

Form Type

4

Issuer CIK

0001819790

Mottiwala Aziz's History

Date Ticker Type Value
2025-06-09 TARS $766K

Other Insiders at TARS (90d)

Insider Bought Sold Last
Neervannan Seshadri
Chief Operating Officer
$200K 2026-03-20